Skip to content

Lymph node metastasis in radiological less-invasive pulmonary adenocarcinoma: a prospective, multicenter and observational study

Lymph node metastasis in radiological less-invasive pulmonary adenocarcinoma: a prospective, multicenter and observational study

Status
Recruiting
Phases
Phase 3
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068464
Enrollment
Unknown
Registered
2023-02-20
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary adenocarcinoma

Interventions

Systematic lymph node dissection group:N/A

Sponsors

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Between 18 and 75 years old; 2. ECOG PS score: 0-1; 3. For patients with multiple pulmonary nodules on chest thin-slice CT, there should be less than 3 nodules on the surgical side, and all of them are radiological low-invasive nodules; 4. The patient's cardiopulmonary function was assessed to be tolerable to anatomical lung resection; 5. According to the guidelines for diagnosis and treatment of primary lung cancer, China (2022 Edition), the purpose of surgery is radical resection; 6. Patients could fully understand the study design; 7. The patient or legal representative should sign the informed consent of this trial.

Exclusion criteria

Exclusion criteria: 1. Previous lung or thoracic surgery or operation history; 2. History of lung or other organ malignant tumor; 3. Complicated with serious other organ diseases and unable to tolerate surgery under general anesthesia.

Design outcomes

Primary

MeasureTime frame
number of lymph node stations, number of dissected lymph nodes;

Countries

China

Contacts

Public ContactXiaotong Guo

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

guoxiaotong@chcamssz.ac.cn+86 188 2388 5351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026